buyWeak
Target N Biotech V bought $588k of MTEM
owner at Molecular Templates, Inc.. 250,000 shares at an average of $2.35, traded Apr 2, 2024, filed Apr 4, 2024.
Conviction score
32Value
$588k
250,000 shares
Holdings after
1,279,820
+24% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +19Trade size$588k at market
- +6Relative to holdingsHoldings up 24%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-042010, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 2, 2024 | POpen-market purchase Common Stock | +250,000 | $2.35 | $588k | 1,279,820 | Apr 4, 2024 |
| Apr 2, 2024 | POpen-market purchase Prefunded Warrants (right to buy)derivative | +134,667 | $2.35 | $316k | 134,667 | Apr 4, 2024 |
| Apr 2, 2024 | POpen-market purchase Common Warrants (right to buy)derivative | +769,334 | $0.13 | $96k | 769,334 | Apr 4, 2024 |
Related signals
Other insiders at Molecular Templates, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | MTEMsell Molecular Templates, Inc. | Target N Biotech V owner | $846k 1,279,820 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.